Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 7, 2010, Pages 496-501

  Liu, Xiang ^a   Feng, Renqing ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

breast carcinoma; c Src; epithelial to mesenchymal transition; PP2; siRNA

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CADHERIN; NERVE PROTEIN; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; RNA BINDING PROTEIN; SIP1 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER; VIMENTIN;

ARTICLE; BREAST TUMOR; CELL LINE; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENETICS; HUMAN; MESODERM; METABOLISM; METASTASIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; HUMANS; MESODERM; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-BINDING PROTEINS; SRC-FAMILY KINASES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 77954394708     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq043     Document Type: Article

References (28)

1. Polyak K and Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9: 265-273.
2. Zeisberg M and Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009, 119: 1429-1437.
3. Geiger TR and Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009, 1796: 293-308.
4. Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002, 2: 442-454.
5. Kang Y and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118: 277-279.
6. Wheeler DL, Iida M and Dunn EF. The role of Src in solid tumors. Oncologist 2009, 14: 667-678.
7. Irby RB and Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000, 19: 5636-5642.
8. Masaki T, Igarashi K, Tokuda M, Yukimasa S, Han F, Jin YJ and Li JQ, et al. pp60c-src activation in lung adenocarcinoma. Eur J Cancer 2003, 39: 1447-1455.
9. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S and Ohshiro K, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008, 112: 2088-2100.
10. Karni R and Levitzki A. pp60(hcSrc) is a caspase-3 substrate and is essential for the transformed phenotype of A431 cells. Mol Cell Biol Res Commun 2000, 3: 98-104.
11. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG and Frame MC. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002, 4: 632-638.
12. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ and Pollok BA, et al. . Discovery of a novel, potent, and Src familyselective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996, 271: 695-701.
13. Lin CY, Lin CJ, Chen KH, Wu JC, Huang SH and Wang SM. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett 2006, 580: 3042-3050.
14. Yang SZ, Zhang LD, Zhang Y, Xiong Y, Zhang YJ, Li HL and Li XW, et al. HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line. Biochem Biophys Res Commun 2009, 382: 555-560.
15. Ulianich L, Garbi C, Treglia AS, Punzi D, Miele C, Raciti GA and Beguinot F, et al. ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells. J Cell Sci 2008, 121: 477-486.
16. Lacroix M and Leclercq G. Relevance of breast cancer cell lines as models for breast tumors: an update. Breast Cancer Res Treat 2004, 83: 249-289.
17. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003, 116: 1409-1416.
18. Hajra KM, Chen DY and Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62: 1613-1618.
19. Martin TA, Goyal A, Watkins G and Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005, 12: 488-496.
20. Leonard M, Chan Y and Menko AS. Identification of a novel intermediate filament-linked N-cadherin/gamma-catenin complex involved in the establishment of the cytoarchitecture of differentiated lens fiber cells. Dev Biol 2008, 319: 298-308.
21. Nam JS, Ino Y, Sakamoto M and Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res 2002, 8: 2430-2436. (Pubitemid 34753619)
22. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002, 3: 155-166.
23. Sivakumar R, Koga H, Selvendiran K, Maeyama M, Ueno T and Sata M. Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelialmesenchymal transition. Int J Oncol 2009, 34: 329-338.
24. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A and Fantoni A, et al. . TGFb-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 2008, 314: 143-152.
25. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY and Peng WL, et al. . Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50: 1464-1474.
26. Marchetti A, Colletti M, Cozzolino AM, Steindler C, Lunadei M, Mancone C and Tripodi M. ERK5/MAPK is activated by TGFbeta in hepatocytes and required for the GSK-3beta-mediated Snail protein stabilization. Cell Signal 2008, 20: 2113-2118.
27. Sosic D, Richardson JA, Yu K, Ornitz DM and Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kB activity. Cell 2003, 112: 169-180.
28. Baek JE, Yang WS, Chang JW, Kim SB, Park SK, Park JS and Lee SK. Fatty acid-bearing albumin induces VCAM-1 expression through c-Src kinase-AP-1/NF-kB pathways: effect of L-carnitine. Kidney Blood Press Res 2010, 33: 72-84.